These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32218820)

  • 1. Salvage stereotactic body radiotherapy for post-operative oligo-recurrence of non-small cell lung cancer: A single-institution analysis of 59 patients.
    Aoki S; Yamashita H; Takahashi W; Nawa K; Ota T; Imae T; Ozaki S; Nozawa Y; Nakajima J; Sato M; Anraku M; Nitadori J; Karasaki T; Abe O; Nakagawa K
    Oncol Lett; 2020 Apr; 19(4):2695-2704. PubMed ID: 32218820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Outcomes and Prognostic Factors of Salvage Stereotactic Body Radiotherapy for Post-Surgical Thoracic Oligo-Recurrence/Metastasis of Non-Small-Cell Lung Cancer.
    Li WC; Wang Z; Gao J; Zhou H; Li J; Zhu XX
    Cancer Manag Res; 2021; 13():1887-1896. PubMed ID: 33654433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study.
    Aoki S; Yamashita H; Haga A; Ota T; Takahashi W; Ozaki S; Nawa K; Imae T; Abe O; Nakagawa K
    Oncol Lett; 2018 Oct; 16(4):4498-4506. PubMed ID: 30214585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of SBRT for lung oligo-recurrence of non-small cell lung cancer: a retrospective analysis.
    Lin Q; Zhou N; Zhu X; Lin J; Fang J; Gu F; Sun X; Wang Y
    J Radiat Res; 2022 Mar; 63(2):272-280. PubMed ID: 34958672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution.
    Doupnik NP; Hirmiz K; Hussein AA; Agapito J; Pan M
    Cureus; 2022 Feb; 14(2):e21878. PubMed ID: 35273848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy.
    Milano MT; Kong FS; Movsas B
    Transl Lung Cancer Res; 2019 Feb; 8(1):78-87. PubMed ID: 30788237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response criteria in solid tumors (PERCIST/RECIST) and SUV
    Pierson C; Grinchak T; Sokolovic C; Holland B; Parent T; Bowling M; Arastu H; Walker P; Ju A
    Radiat Oncol; 2018 Feb; 13(1):34. PubMed ID: 29486779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity.
    Miszczyk M; Kraszkiewicz M; Moll M; Kaminiów K; Sobel S; Dolla Ł; Wojcieszek P; Rajwa P; Yanagisawa T; Nowicka Z; Shariat SF; Goldner G; Miszczyk L; Majewski W
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT.
    Hörner-Rieber J; Bernhardt D; Blanck O; Duma M; Eich HT; Gerum S; Gkika E; Hass P; Henkenberens C; Herold HU; Hildebrandt G; Imhoff D; Kahl H; Janssen S; Jurianz K; Krempien R; Lautenschläger SF; Lohaus F; Mueller AC; Petersen C; Sackerer I; Scafa D; Schrade E; Uhlmann L; Wittig A; Guckenberger M
    Clin Lung Cancer; 2019 Nov; 20(6):e667-e677. PubMed ID: 31327644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year follow-up after stereotactic body radiotherapy for medically inoperable early-stage non-small cell lung cancer: a multicenter study.
    Guo Y; Zhu Y; Zhang R; Yang S; Kepka L; Viani GA; Milano MT; Sio TT; Sun X; Wu H; Xing L; Xu Y
    Transl Lung Cancer Res; 2023 Jun; 12(6):1293-1302. PubMed ID: 37425405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
    Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
    Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
    Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of stereotactic radiotherapy on elderly patients with stage I-II central non-small cell lung cancer.
    Ji X; Zhou B; Huang H; Wang Y; Jiang W; Wang J; Ding W; Wang Z; Chen G; Sun X
    Front Oncol; 2024; 14():1235630. PubMed ID: 38803531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisite stereotactic body radiotherapy for metastatic non-small-cell lung cancer: Delaying the need to start or change systemic therapy?
    Merino Lara T; Helou J; Poon I; Sahgal A; Chung HT; Chu W; Soliman H; Ung Y; Verma S; Cheema P; Cheng S; Khanna S; Erler D; Zhang L; Cheung P
    Lung Cancer; 2018 Oct; 124():219-226. PubMed ID: 30268464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiation Therapy as Salvage for Intrathoracic Recurrence in Patients With Previously Irradiated Locally Advanced Non-Small Cell Lung Cancer.
    Parks J; Kloecker G; Woo S; Dunlap NE
    Am J Clin Oncol; 2016 Apr; 39(2):147-53. PubMed ID: 24457534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage surgery to treat tumor regrowth after stereotactic body radiotherapy in primary non-small cell lung cancer.
    Koizumi T; Aoki T; Saito M; Yamato Y; Furuyashiki G; Kitahara A; Hashimoto T; Watanabe T; Tsuchida M
    J Thorac Dis; 2020 Oct; 12(10):5289-5298. PubMed ID: 33209363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.